France remedies pharmaceutical deal following EU referral

France’s Competition Authority has conditionally approved Phoenix Group’s €1.5 billion acquisition of McKesson’s European businesses, after asking the European Commission for permission to review national aspects of a deal for only the fourth time.

Unlock unlimited access to all Global Competition Review content